Stockscreener 앱 받기
1.15
3.60%
0.04
시장 영업 전:
1.15
전일 마감가:
$1.11
열려 있는:
$1.12
하루 거래량:
111.48K
Relative Volume:
0.39
시가총액:
$54.90M
수익:
$2.72M
순이익/손실:
$-85.08M
주가수익비율:
-0.5959
EPS:
-1.93
순현금흐름:
$-70.93M
1주 성능:
+2.68%
1개월 성능:
+0.00%
6개월 성능:
-73.86%
1년 성능:
-87.25%
1일 변동 폭
$1.11
$1.21
1주일 범위
$1.06
$1.22
52주 변동 폭
$0.94
$11.76
셰턱랩스 Stock (STTK) Company Profile
명칭
Shattuck Labs Inc
전화
512-900-4690
주소
500 W. 5TH STREET, AUSTIN
STTK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
1.15 | 54.90M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
셰턱랩스 Stock (STTK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-10-02 | 다운그레이드 | Needham | Buy → Hold |
| 2024-10-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-06-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-08-31 | 개시 | BTIG Research | Buy |
| 2022-06-01 | 개시 | Citigroup | Buy |
| 2022-05-02 | 개시 | H.C. Wainwright | Buy |
| 2021-04-14 | 개시 | Berenberg | Buy |
| 2021-01-11 | 개시 | Evercore ISI | Outperform |
| 2020-11-03 | 개시 | Citigroup | Buy |
| 2020-11-03 | 개시 | Cowen | Outperform |
| 2020-11-03 | 개시 | Needham | Buy |
모두보기
셰턱랩스 주식(STTK)의 최신 뉴스
Barclays PLC Has $189,000 Stock Holdings in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Layoff Tracker: Notch Therapeutics to ‘Significantly Reduce’ Workforce - BioSpace
Shattuck Labs, Inc. (NASDAQ:STTK) Shares Sold by Jane Street Group LLC - Defense World
Barclays PLC Buys 40,717 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Geode Capital Management LLC Raises Position in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Shattuck Labs CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Shattuck Labs highlights upcoming key milestones in 2025 - Yahoo Finance
Shattuck Labs gears up for DR3 antagonist trials in 2025 By Investing.com - Investing.com Australia
Shattuck Labs gears up for DR3 antagonist trials in 2025 - Investing.com
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025 - The Manila Times
Shattuck Labs Unveils 2025 Pipeline Roadmap: Key SL-325 Clinical Milestones, $90M Cash Position - StockTitan
State Street Corp Acquires 55,579 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Barfresh Food Group And 2 Other US Penny Stocks To Consider - Simply Wall St
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm - The Eastern Progress Online
MetLife Investment Management LLC Raises Holdings in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Marketscreener.com
Shattuck Labs, Inc. (NASDAQ:STTK) Director Buys $166,713.75 in Stock - MarketBeat
Redmile Group, LLC Reduces Stake in Shattuck Labs Inc - GuruFocus.com
Shattuck Labs sees $166,713 in stock sales by Redmile Group - Investing.com
GSA Capital Partners LLP Invests $121,000 in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Shattuck Labs to Present at Piper Sandler and Evercore Healthcare Conferences | STTK Stock News - StockTitan
Shattuck Labs Falls To US$1.01, But Insiders Sold At Lower Price - Simply Wall St
Shattuck Labs stock plunges to 52-week low at $1.06 By Investing.com - Investing.com Canada
Shattuck Labs stock plunges to 52-week low at $1.06 - Investing.com India
Citigroup Downgrades Shattuck Labs (STTK) - MSN
Shattuck Labs’ (STTK) Neutral Rating Reaffirmed at HC Wainwright - Defense World
Shattuck Labs Focuses on Promising Antibody Development - TipRanks
Shattuck Labs FY2024 EPS Forecast Decreased by HC Wainwright - MarketBeat
HC Wainwright Lowers Earnings Estimates for Shattuck Labs - Defense World
Shattuck Labs Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
STTK (Shattuck Labs) Degree of Operating Leverage : -0.01 (As of Jun. 2024) - GuruFocus.com
Shattuck Labs' (STTK) "Neutral" Rating Reiterated at HC Wainwright - MarketBeat
Shattuck Labs sees cash runway into 2027 - Yahoo Finance
Shattuck Labs Inc (STTK) Quarterly 10-Q Report - Quartz
Shattuck Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Shattuck Labs Inc (STTK) Q3 2024 Earnings: Revenue Soars to $3.0M, EPS Loss of $0.33 Beats Estimates - GuruFocus.com
Shattuck Labs Reports Third Quarter 2024 Financial Results and Recent Business Highlights - The Manila Times
Shattuck Labs Narrows Q3 Loss, Pivots Focus to SL-325 with $90.1M Cash Runway | STTK Stock News - StockTitan
Prosight Management, LP Expands Stake in Shattuck Labs Inc - GuruFocus.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc.STTK - PR Newswire
FMR LLC's Strategic Reduction in Shattuck Labs Inc Holdings - GuruFocus.com
Vanguard Group Inc's Strategic Acquisition in Shattuck Labs Inc - GuruFocus.com
Shattuck Labs, Inc. (NASDAQ:STTK) Short Interest Down 60.0% in October - Defense World
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC - GlobeNewswire
셰턱랩스 (STTK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
셰턱랩스 주식 (STTK) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Redmile Group, LLC | Director |
Dec 04 '24 |
Sale |
1.25 |
133,371 |
166,714 |
5,406,353 |
4.81%
자본화:
|
볼륨(24시간):